In questo sito vengono utilizzati cookies tecnici necessari alla fruizione del sito stesso. Vengono inoltre utilizzati cookies di terze parti (google) per la raccolta di informazioni sulla fruzione del sito. Non vengono in alcun modo raccolte informazioni in grado identificare gli utenti. Le informazioni raccolte non vengono in alcun modo cedute ad altri soggetti.
>> news
caffe' e cancro : protegge dal cancro del cavo orale / Annals of oncology) [30/10/2010]

 Il  consumo di caffe' caffe' protegge dal cancro della mucosa orale e  faringe  ; non incide sul cancro dell'esofago   o della laringe

Coffee and cancers of the upper digestive and respiratory tracts: meta-analyses of observational studies
Abstract
Background: Data of epidemiological studies on the relation between coffee drinking and upper aerodigestive tract cancer risk are scattered and inconclusive. We therefore conducted systematic meta-analyses of observational studies published before October 2009.
Materials and methods: We combined relative risks (RR) with 95% confidence intervals (CI) for cancers of the oral cavity/pharynx (OP) and larynx, esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC), comparing the highest versus the lowest categories of coffee consumption, using random-effects models.
Results: For OP cancer, the pooled RR was 0.64 (95% CI 0.51–0.80) for highest versus lowest coffee drinking, based on a total of 2633 cases from one cohort and eight case–control studies, with no significant heterogeneity across studies. The RRs were 0.61 (95% CI 0.41–0.89) for European, 0.58 (95% CI 0.36–0.94) for American and 0.74 (95% CI 0.48–1.15) for Asian studies, where coffee consumption is lower. The corresponding RRs were 1.56 (95% CI 0.60–4.02) for laryngeal cancer (732 cases from three case–control studies), 0.87 (95% CI 0.65–1.17) for ESCC (2115 cases from one cohort and six case–control studies) and 1.18 (95% CI 0.81–1.71) for EAC (415 cases from three case–control studies).
Conclusion: Coffee drinking is inversely related to OP cancer risk, while there is no relation with laryngeal cancer, ESCC and EAC.
Key words
  1. F. Turati1,2,
  2. C. Galeone1,2,
  3. C. La Vecchia1,2,
  4. W. Garavello1,3 and
  5. A. Tavani1,*
+ Author Affiliations
  1. 1Department of Epidemiology, Istituto di Ricerche Farmacologiche “Mario Negri”, Milan
  2. 2Department of Occupational Health “Clinica del Lavoro Luigi Devoto”, Section of Medical Statistics “Giulio A. Maccacaro”, Università degli Studi di Milano, Milan
  3. 3Department of Otorhinolaryngology, Università degli Studi di Milano-Bicocca, Monza, Italy
  1. *Correspondence to: Dr A. Tavani, Istituto di Ricerche Farmacologiche “Mario Negri”, Via G. La Masa 19, 20157 Milan, Italy. Tel: +39-02-39-01-47-22; Fax: +39-02-33-20-02-31; E-mail: alessandra.tavani@marionegri.it

             

::::::    Creato il : 16/10/2010 da Magarotto Roberto    ::::::    modificato il : 30/10/2010 da Magarotto Roberto    ::::::